PFE off on Celebrex data

Pfizer (PFE) closed down $3.23 (11%) to $25.75 on 290 million shares after reporting that Celebrex celecoxib showed an increased risk of cardiovascular events in the long-term APC study in

Read the full 300 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE